NASDAQ:AEGR - Aegerion Pharmaceuticals Stock Price, Forecast & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Aegerion Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $1.97 0.00 (0.00 %) (As of 12/7/2016) Add Today's Range$1.97Now: $1.97▼$1.9750-Day Range$1.97MA: $1.97▼$1.9752-Week Range$1.23Now: $1.97▼$10.85VolumeN/AAverage Volume635,262 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Aegerion Pharmaceuticals, Inc is a biopharmaceutical company engaged in the development and commercialization of therapies for patients with debilitating rare diseases. It operates through pharmaceuticals segment. Its products include lomitapide and metreleptin. Lomitapide is a small molecule microsomal triglyceride transfer protein (MTP) inhibitor. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryBiotechnology SectorN/A Current SymbolNASDAQ:AEGR Previous Symbol CUSIP00767E10 CIK1338042 Webhttp://www.aegerion.com/ Phone+1-617-5007867Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Receive AEGR News and Ratings via Email Sign-up to receive the latest news and ratings for AEGR and its competitors with MarketBeat's FREE daily newsletter. Aegerion Pharmaceuticals (NASDAQ:AEGR) Frequently Asked Questions What is Aegerion Pharmaceuticals' stock symbol? Aegerion Pharmaceuticals trades on the NASDAQ under the ticker symbol "AEGR." How were Aegerion Pharmaceuticals' earnings last quarter? Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) posted its quarterly earnings results on Monday, May, 16th. The biopharmaceutical company reported ($1.72) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.58) by $1.14. The biopharmaceutical company had revenue of $35.70 million for the quarter, compared to the consensus estimate of $43 million. Aegerion Pharmaceuticals's revenue was down 39.9% on a year-over-year basis. During the same quarter last year, the company earned ($0.55) EPS. View Aegerion Pharmaceuticals' Earnings History. Has Aegerion Pharmaceuticals been receiving favorable news coverage? News headlines about AEGR stock have been trending extremely negative on Monday, InfoTrie Sentiment reports. The research firm scores the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Aegerion Pharmaceuticals earned a media sentiment score of -4.5 on InfoTrie's scale. They also assigned news stories about the biopharmaceutical company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the near term. View News Stories for Aegerion Pharmaceuticals. Who are some of Aegerion Pharmaceuticals' key competitors? Some companies that are related to Aegerion Pharmaceuticals include Amgen (AMGN), Gilead Sciences (GILD), Celgene (CELG), Vertex Pharmaceuticals (VRTX), Biogen (BIIB), Regeneron Pharmaceuticals (REGN), Alexion Pharmaceuticals (ALXN), Seattle Genetics (SGEN), Incyte (INCY), BioMarin Pharmaceutical (BMRN), Alnylam Pharmaceuticals (ALNY), EXACT Sciences (EXAS), Neurocrine Biosciences (NBIX), Ionis Pharmaceuticals (IONS) and Exelixis (EXEL). What other stocks do shareholders of Aegerion Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Aegerion Pharmaceuticals investors own include Allergan (AGN), BioMarin Pharmaceutical (BMRN), Netflix (NFLX), Tesla (TSLA), Ariad Pharmaceuticals (ARIA), Arrowhead Pharmaceuticals (ARWR), Celgene (CELG), Gilead Sciences (GILD), Intercept Pharmaceuticals (ICPT) and Keryx Biopharmaceuticals (KERX). What is Aegerion Pharmaceuticals' stock price today? One share of AEGR stock can currently be purchased for approximately $1.97. What is Aegerion Pharmaceuticals' official website? The official website for Aegerion Pharmaceuticals is http://www.aegerion.com/. How can I contact Aegerion Pharmaceuticals? Aegerion Pharmaceuticals' mailing address is 1 Main St Ste 800, CAMBRIDGE, MA 02142-1531, United States. The biopharmaceutical company can be reached via phone at +1-617-5007867. MarketBeat Community Rating for Aegerion Pharmaceuticals (NASDAQ AEGR)Community Ranking: 2.7 out of 5 ( )Outperform Votes: 386 (Vote Outperform)Underperform Votes: 317 (Vote Underperform)Total Votes: 703MarketBeat's community ratings are surveys of what our community members think about Aegerion Pharmaceuticals and other stocks. Vote "Outperform" if you believe AEGR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AEGR will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/27/2020 by MarketBeat.com StaffFeatured Article: What is a Real Estate Investment Trust (REIT)?